Published • loading... • Updated
Nurix Therapeutics (NASDAQ:NRIX) Releases Earnings Results
Summary by MarketBeat
3 Articles
3 Articles
Nurix Therapeutics (NASDAQ:NRIX) Releases Earnings Results
Nurix Therapeutics (NASDAQ:NRIX - Get Free Report) issued its quarterly earnings data on Monday. The company reported $4.73 EPS for the quarter, topping analysts' consensus estimates of ($0.60) by $5.33. Nurix Therapeutics had a negative net margin of 928.44% and a negative return on equity of 76.09%.
·Sioux Falls, United States
Read Full Article
Nurix Therapeutics (NASDAQ:NRIX) Issues Quarterly Earnings Results, Beats Expectations By $5.33 EPS
Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) issued its quarterly earnings data on Monday. The company reported $4.73 EPS for the quarter, beating analysts’ consensus estimates of ($0.60) by $5.33, Zacks reports. Nurix Therapeutics had a negative return on equity of 76.09% and a negative net margin of 928.44%. Nurix Therapeutics Stock Down 0.9% NASDAQ:NRIX […]
Coverage Details
Total News Sources3
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
